CRXT insider filings

Clarus Therapeutics Holdings, Inc. — 24 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2022-06-09. Screen CRXT transaction legs live →

Insider transaction summary — last 90 days

No insider filings (Forms 3/4/5) for CRXT between 2026-08-23 and 2026-11-21. The table below lists the most recent filings on record.

Recent insider filings — Clarus Therapeutics Holdings, Inc.

FiledFormInsiderReported transactionsSource
2022-06-094Amory John Kenneth — DirectorGrant/award (A): 1,922 @ $0 · Grant/award (A): 4,805 (derivative) @ $0EDGAR
2022-06-094Murphy Kimberly M — DirectorGrant/award (A): 1,922 @ $0 · Grant/award (A): 4,805 (derivative) @ $0EDGAR
2022-06-094Hernandez Joseph — DirectorGrant/award (A): 1,922 @ $0 · Grant/award (A): 4,805 (derivative) @ $0EDGAR
2022-06-094Cermak Elizabeth — DirectorGrant/award (A): 1,922 @ $0 · Grant/award (A): 4,805 (derivative) @ $0EDGAR
2022-06-094PRYGOCKI MARK A SR — DirectorGrant/award (A): 1,922 @ $0 · Grant/award (A): 4,805 (derivative) @ $0EDGAR
2022-04-274Hernandez Joseph — DirectorOther (J): 65,000 @ $0 · Other (J): 1,237,500 @ $0 · Grant/award (A): 3,445,000 (derivative) @ $1EDGAR
2022-04-254/ATHOMAS MCNERNEY & PARTNERS LP — 10% owner
TMP ASSOCIATES LP — 10% owner
TMP Nominee, LLC — 10% owner
Thomas, McNerney & Partners, LLC — 10% owner
Thomas, McNerney & Partners II L.P. — 10% owner
TMP Associates II LP — 10% owner
TMP Nominee II, LLC — 10% owner
Thomas, McNerney & Partners II, LLC — 10% owner
THOMAS JAMES E — 10% owner
Sale (S): 1,663,126 @ $2.53 · Sale (S): 2,061,685 @ $2.53 · Sale (S): 5,722 @ $2.53 · Sale (S): 13,630 @ $2.53 · Sale (S): 1,164 @ $2.53 · Sale (S): 7,585 @ $2.53EDGAR
2022-04-214THOMAS MCNERNEY & PARTNERS LP — 10% owner
TMP ASSOCIATES LP — 10% owner
TMP Nominee, LLC — 10% owner
Thomas, McNerney & Partners, LLC — 10% owner
Thomas, McNerney & Partners II L.P. — 10% owner
TMP Associates II LP — 10% owner
TMP Nominee II, LLC — 10% owner
Thomas, McNerney & Partners II, LLC — 10% owner
THOMAS JAMES E — 10% owner
Sale (S): 1,663,126 @ $2.53 · Sale (S): 2,061,685 @ $2.53 · Sale (S): 5,722 @ $2.53 · Sale (S): 13,630 @ $2.53 · Sale (S): 1,164 @ $2.53 · Sale (S): 7,585 @ $2.53EDGAR
2021-12-144Jaeger Frank — Chief Commercial OfficerGrant/award (A): 29,000 @ $0 · Grant/award (A): 72,500 (derivative) @ $0EDGAR
2021-12-144Amory John Kenneth — DirectorGrant/award (A): 3,844 @ $0 · Grant/award (A): 9,610 (derivative) @ $0EDGAR
2021-12-144Murphy Kimberly M — DirectorGrant/award (A): 3,844 @ $0 · Grant/award (A): 9,610 (derivative) @ $0EDGAR
2021-12-144Hernandez Joseph — DirectorGrant/award (A): 3,844 @ $0 · Grant/award (A): 9,610 (derivative) @ $0EDGAR
2021-12-144Dudley Robert E. — Chief Executive Officer, DirectorGrant/award (A): 135,000 @ $0 · Grant/award (A): 337,500 (derivative) @ $0EDGAR
2021-12-144Bourne Steven A. — Chief Administrative OfficerGrant/award (A): 29,000 @ $0 · Grant/award (A): 72,500 (derivative) @ $0EDGAR
2021-12-144Cermak Elizabeth — DirectorGrant/award (A): 3,844 @ $0 · Grant/award (A): 9,610 (derivative) @ $0EDGAR
2021-12-144PETERSON RICHARD D — Chief Financial OfficerGrant/award (A): 55,800 @ $0 · Grant/award (A): 139,500 (derivative) @ $0EDGAR
2021-12-144PRYGOCKI MARK A SR — DirectorGrant/award (A): 3,844 @ $0 · Grant/award (A): 9,610 (derivative) @ $0EDGAR
2021-10-044H.I.G. Ventures - Clarus, LLC — 10% owner
H.I.G. Bio-Clarus II, L.P. — 10% owner
H.I.G. Bio-Clarus I, L.P. — 10% owner
H.I.G.-GPII, Inc. — 10% owner
TAMER ANTHONY — 10% owner
MNAYMNEH SAMI — 10% owner
Grant/award (A): 490,531 @ $0 · Grant/award (A): 2,731,094 @ $0 · Grant/award (A): 2,470,756 @ $0EDGAR
2021-09-234/AHernandez Joseph — Director
Blue Water Sponsor LLC
Option exercise (M): 1,437,500 @ $0 · Other (J): 135,000 @ $0 · Option exercise (M): 1,437,500 (derivative) @ $0 · Grant/award (A): 3,445,000 (derivative) @ $1EDGAR
2021-09-214FFI FUND LTD — 10% owner
FYI Ltd — 10% owner
Olifant Fund, Ltd. — 10% owner
Bracebridge Capital, LLC — 10% owner
Sale (S): 127,360 @ $9.20EDGAR
2021-09-134Zisson Alex — Director, 10% ownerGrant/award (A): 490,531 @ $0 · Grant/award (A): 2,731,094 @ $0 · Grant/award (A): 2,470,756 @ $0EDGAR
2021-09-134Dudley Robert E. — Chief Executive Officer, DirectorGrant/award (A): 4,566 @ $0EDGAR
2021-09-134Bourne Steven A. — Chief Administrative OfficerGrant/award (A): 1,305 @ $0EDGAR
2021-09-134Hernandez Joseph — Director
Blue Water Sponsor LLC
Option exercise (M): 1,437,500 @ $0 · Other (J): 135,000 @ $0 · Option exercise (M): 1,437,500 (derivative) @ $0 · Grant/award (A): 3,445,000 (derivative) @ $1EDGAR

Recent 8-K events — Clarus Therapeutics Holdings, Inc.

Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →

FiledFormItems reportedSource
2023-03-018-K1.03 — Bankruptcy or Receivership
2.01 — Completion of Acquisition or Disposition of Assets
3.03 — Material Modification to Rights of Security Holders
5.01 — Changes in Control of Registrant
5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
8.01 — Other Events
EDGAR
2023-02-228-K7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2023-01-248-K7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2022-12-228-K7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2022-11-238-K7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2022-10-318-K1.01 — Entry into a Material Definitive Agreement
2.01 — Completion of Acquisition or Disposition of Assets
5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2022-10-248-K7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2022-10-188-K8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2022-09-158-K4.01 — Changes in Registrant's Certifying Accountant
9.01 — Financial Statements and Exhibits
EDGAR
2022-09-068-K1.03 — Bankruptcy or Receivership
5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?ticker=CRXT returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs